Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12 Items
Title  Creator  Group name  Publishing year 
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort Webb et al. EquipeJPP 2022-10
Improving Patients' Life Quality after Radiotherapy Treatment by Predicting Late Toxicities Lapierre et al. EquipeJPP 2022-04-22
Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer Mali?i? et al. EquipeJPP 2022-12-09
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia Xiong et al. EquipeAP 2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity Franco et al. EquipeJPP 2021-06
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer Seibold et al. EquipeAP May 27, 2019
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity Lacombe et al. EquipePC Aug 09, 2019
Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity Talbot et al. EquipeJPP 2019-09
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator Azria et al. EquipeAP 2018
In Regard to Pereira et al Azria et al. EquipeAP Jun 01, 2018
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial Bourgier et al. EquipeNB Mar 20, 2018
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era Azria et al. EquipeJC 2017
12 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés